158 related articles for article (PubMed ID: 28204853)
21. Improved detection of hepatic metastases of adrenocortical cancer by contrast-enhanced ultrasound.
Bauditz J; Quinkler M; Beyersdorff D; Wermke W
Oncol Rep; 2008 May; 19(5):1135-9. PubMed ID: 18425368
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
[TBL] [Abstract][Full Text] [Related]
23. Computed tomography and magnetic resonance imaging of hepatic metastases.
Sica GT; Ji H; Ros PR
Clin Liver Dis; 2002 Feb; 6(1):165-79, vii. PubMed ID: 11933587
[TBL] [Abstract][Full Text] [Related]
24. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging.
Hekimoglu K; Ustundag Y; Dusak A; Kalaycioglu B; Besir H; Engin H; Erdem O
Eur J Radiol; 2011 Mar; 77(3):468-72. PubMed ID: 19781882
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
[No Abstract] [Full Text] [Related]
26. MR imaging in the evaluation of hepatic metastases.
Imam K; Bluemke DA
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):741-56. PubMed ID: 11149677
[TBL] [Abstract][Full Text] [Related]
27. Magnetic Resonance Imaging of Liver Metastasis.
Karaosmanoglu AD; Onur MR; Ozmen MN; Akata D; Karcaaltincaba M
Semin Ultrasound CT MR; 2016 Dec; 37(6):533-548. PubMed ID: 27986172
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
29. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement.
Hong HS; Byun JH; Won HJ; Kim KW; Lee SS; Lee MG; Yun SC
Clin Radiol; 2010 Sep; 65(9):701-7. PubMed ID: 20696297
[TBL] [Abstract][Full Text] [Related]
30. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
[TBL] [Abstract][Full Text] [Related]
32. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
33. Comparison of macroscopic pathology measurements with magnetic resonance imaging and assessment of microscopic pathology extension for colorectal liver metastases.
Méndez Romero A; Verheij J; Dwarkasing RS; Seppenwoolde Y; Redekop WK; Zondervan PE; Nowak PJ; Ijzermans JN; Levendag PC; Heijmen BJ; Verhoef C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):159-66. PubMed ID: 21183292
[TBL] [Abstract][Full Text] [Related]
34. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.
Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE
Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057
[TBL] [Abstract][Full Text] [Related]
36. Radiological staging of colorectal liver metastases.
Ong KO; Leen E
Surg Oncol; 2007 Jul; 16(1):7-14. PubMed ID: 17499498
[TBL] [Abstract][Full Text] [Related]
37. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
[TBL] [Abstract][Full Text] [Related]
38. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
39. Imaging of liver metastases: MRI.
Namasivayam S; Martin DR; Saini S
Cancer Imaging; 2007; 7(1):2-9. PubMed ID: 17293303
[TBL] [Abstract][Full Text] [Related]
40. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
